Replacement of the lost myelin sheath is a therapeutic goal for treating demyelinating
diseases of the central nervous system (CNS), such as multiple sclerosis (MS). The G protein (…

Background: Lilly/Avid's AV‐1451 is one of the most advanced tau PET tracers in the clinic.
Although results obtained in Alzheimer's disease patients are compelling, discrimination of …

Excitatory transmission in the CNS necessitates the existence of dynamic controls of the
glutamate uptake achieved by astrocytes, both in physiological conditions and under …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a
selective loss of motor neurones accompanied by intense gliosis in lesioned areas of the brain …

Background:[18F] T807 is currently being tested in humans as a tau positron emission
tomography (PET) tracer. Described as selectively binding to tau aggregates as opposed to Ab or …

Identification of additional uses for existing drugs is a hot topic in drug discovery and a
viable alternative to de novo drug development. HAMI3379 is known as an antagonist of the …

Nasopharyngeal swabs are considered the preferential collection method for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics. Less invasive and simpler …

Pairing orphan G protein–coupled receptors (GPCRs) with their cognate endogenous ligands
is expected to have a major impact on our understanding of GPCR biology. It follows that …

IS231A was originally discovered in Bacillus thuringiensis as a typical 1.6 kb insertion
sequence (IS) displaying 20 bp inverted repeats (IR) flanking a transposase gene. A first major …

Adult bone marrow mesenchymal stem cells are multipotent cells that can differentiate into a
variety of mesodermal tissues. Recent studies have reported on their ability to also evolve …